Washington, D.C. – In response to broad and misleading claims in a recent Government Accountability Office (GAO) report, leading clinical laboratory, diagnostic and provider organizations challenged the agency on a number of recommendations that could lead to disruption to seniors’ access to critical laboratory diagnostics.
The joint letter from AdvaMedDx, American Clinical Laboratory Association (ACLA), College of American Pathologists (CAP), National Independent Laboratory Association (NILA) and Point of Care Testing Association (POCTA) notes that GAO makes flawed assertions related to laboratory billing in the Medicare program and implementation of the Protecting Access to Medicare Act (PAMA). Highlights from the letter are included below:
To view the full letter, click here.
About the American Clinical Laboratory Association (ACLA)
ACLA is a not-for-profit association representing the nation’s leading clinical and anatomic pathology laboratories, including national, regional, specialty, hospital, ESRD and nursing home laboratories. The clinical laboratory industry employs nearly 277,000 people directly and generates over 115,000 additional jobs in supplier industries. Clinical laboratories are at the forefront of personalized medicine, driving diagnostic innovation and contributing more than $100 billion to the nation’s economy.
AdvaMedDx member companies produce innovative, high quality in vitro diagnostic tests that facilitate evidence-based medicine, improve quality of patient care, promote wellness, enable early detection of disease and can reduce overall health care costs. Functioning as an association within AdvaMed, AdvaMedDx is dedicated to the issues facing in vitro diagnostic companies in the United States and abroad.
About the College of American Pathologists (CAP)
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the 2017 CAP Annual Report at CAP.ORG.
About the National Independent Laboratory Association (NILA)
NILA members are independent community and regional clinical laboratories working with physician practices, hospitals, outpatient care settings, skilled nursing facilities and home health patients to provide essential clinical laboratory services to Medicare beneficiaries, particularly those in underserved communities and hard to reach care settings.
About the Point of Care Testing Association (POCTA)
The Point of Care Testing Association seeks to facilitate access to safe, effective, and cost-effective patient testing at the time of treatment. The POCTA educates providers, payers, and patients about the benefits of point-of-care testing, and it advocates for public policies that foster innovation in and appropriate use of point-of-care testing. The POCTA works with public and private payers to develop reimbursement policies that can improve health outcomes by supporting access to point-of-care testing.